Trial intelligence / Profile preview

Phase 3 study of tanezumab versus tramadol in Japan

jRCT2080223061Phase 3Completed

Start
Jan 2016
Modality
Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
01

Overview

Phase 3, randomised trial of tanezumab in chronic pain (2 arms). Started Jan 2016; status: completed.

02

Drugs

tanezumab
03

Conditions

chronic pain

Beyond the preview

Go deeper on jRCT2080223061.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080223061.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call